Which trial do we need? Comparison of 7 versus 14 days of antibiotic therapy for ventilator-associated pneumonia due to highly resistant gram-negative bacteria

被引：1
|
作者：
Tleyjeh, Imad M. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] King Fahad Med City, Dept Med Specialties, Infect Dis Sect, Riyadh, Saudi Arabia
[2] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia
[3] Mayo Clin, Coll Med & Sci, Div Publ Hlth Infect Dis & Occupat Med, Rochester, MN USA
[4] Mayo Clin, Coll Med & Sci, Div Epidemiol, Rochester, MN USA
[5] King Fahd Med City, Sect Infect Dis, POB 59046, Riyadh 11525, Saudi Arabia
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2023年 / 29卷 / 09期
关键词：
Drug resistance; Gram-negative bacteria; Pneumonia; Short-course therapy; Ventilator; Trial design considerations; INFECTIOUS-DISEASES SOCIETY; DURATION; AMERICA;
D O I：
10.1016/j.cmi.2023.04.018
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1114 / 1116
页数：3
相关论文
共 50 条
  • [31] Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
    Yahav, Dafna
    Franceschini, Erica
    Koppel, Fidi
    Turjeman, Adi
    Babich, Tanya
    Bitterman, Roni
    Neuberger, Ami
    Ghanem-Zoubi, Nesrin
    Santoro, Antonella
    Eliakim-Raz, Noa
    Pertzov, Barak
    Steinmetz, Tali
    Stern, Anat
    Dickstein, Yaakov
    Maroun, Elias
    Zayyad, Hiba
    Bishara, Jihad
    Alon, Danny
    Edel, Yonatan
    Goldberg, Elad
    Venturelli, Claudia
    Mussini, Cristina
    Leibovici, Leonard
    Paul, Mical
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (07) : 1091 - 1098
  • [32] Which trial do we need? Highly bioavailable oral β-lactams versus quinolones or trimethoprim-sulfamethoxazole for gram-negative bacteraemia
    Tong, Steven Y. C.
    Yahav, Dafna
    Daneman, Nick
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (09) : 1110 - 1113
  • [33] Rotation and restricted use of antibiotics in a medical intensive cave unit - Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria
    Gruson, D
    Hilbert, G
    Vargas, F
    Valentino, R
    Bebear, C
    Allery, A
    Bebear, C
    Gbikpi-Benissan, G
    Cardinaud, JP
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (03) : 837 - 843
  • [34] Which trial do we need? Treatment of multiple erythema migrans with doxycycline for 7 days versus 14 days
    Stupica, Dasa
    Collinet-Adler, Stefan
    Kejzar, Natasa
    Veluscek, Masa
    Borsic, Katarina
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (02) : 159 - 161
  • [35] Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: A systematic review and meta-analysis
    Gua, Wan-Jie
    Wang, Fei
    Tang, Lu
    Bakker, Jan
    Liu, Jing-Chen
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (06) : 477 - 485
  • [36] Duration of Antibiotic Therapy in Neonatal Gram-negative Bacterial Sepsis-10 Days Versus 14 Days A Randomized Controlled Trial
    Fursule, Anurag
    Thakur, Anup
    Garg, Pankaj
    Kler, Neelam
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (02) : 156 - 160
  • [37] VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT GRAM-NEGATIVE BACTERIA IN 13 GREEK ADULTS ICUS: EPIDEMIOLOGY AND IMPACT ON ICU MORTALITY
    Mouloudi, E.
    Papanikolaou, S.
    Karvouniaris, M.
    Aslanidis, T.
    Sakagianni, A.
    Michelidou, S.
    Pontikis, K.
    Gavala, A.
    Chouris, I.
    Rempelakos, G.
    Nikolaou, C.
    Antipa, E.
    Papadomichelakis, E.
    Arvaniti, K.
    Myrianthefs, P.
    INTENSIVE CARE MEDICINE, 2014, 40 : S99 - S99
  • [38] Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta
    Rouby, Jean-Jacques
    Zhu, Yinggang
    Torres, Antoni
    Rello, Jordi
    Monsel, Antoine
    ANNALS OF INTENSIVE CARE, 2022, 12 (01)
  • [39] Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta
    Jean-Jacques Rouby
    Yinggang Zhu
    Antoni Torres
    Jordi Rello
    Antoine Monsel
    Annals of Intensive Care, 12
  • [40] Empiric, broad-spectrum antibiotic therapy with de-escalation for ventilator-associated pneumonia does not induce gram-negative pathogen resistance
    Kopelman, Tammy R.
    O'Neill, Patrick J.
    Hibbard, Michael L.
    Matthews, Marc R.
    Cox, Jordy C.
    Quan, Asia N.
    Drachman, David A.
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A232 - A232
12345